Stifel Financial Corp Tekla Life Sciences Investors Transaction History
Stifel Financial Corp
- $93.7 Billion
- Q4 2024
A detailed history of Stifel Financial Corp transactions in Tekla Life Sciences Investors stock. As of the latest transaction made, Stifel Financial Corp holds 28,341 shares of HQL stock, worth $369,283. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,341
Previous 16,963
67.08%
Holding current value
$369,283
Previous $255,000
45.49%
% of portfolio
0.0%
Previous 0.0%
Shares
30 transactions
Others Institutions Holding HQL
# of Institutions
79Shares Held
9.65MCall Options Held
0Put Options Held
0-
Saba Capital Management, L.P. New York, NY3.43MShares$44.7 Million1.11% of portfolio
-
Penserra Capital Management LLC Orinda, CA828KShares$10.8 Million0.2% of portfolio
-
Karpus Management, Inc. Pittsford, NY490KShares$6.38 Million0.23% of portfolio
-
Sit Investment Associates Inc Minneapolis, MN417KShares$5.43 Million0.12% of portfolio
-
Absolute Investment Advisers LLC400KShares$5.21 Million0.67% of portfolio
About TEKLA LIFE SCIENCES INVESTORS
- Ticker HQL
- Exchange NYSE
- Sector Financial Services
- Industry Asset Management
- Description
- Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...